FDA Guidance for Industry: Transdermal and Topical Delivery Systems - Product Development 1 and Quality Considerations

Titel:
FDA Guidance for Industry: Transdermal and Topical Delivery Systems - Product Development 1 and Quality Considerations
Herkunft/Verlag:

FDA

Inhalt:
This guidance provides recommendations to applicants and manufacturers of transdermal and topical delivery systems (TDS)2 regarding the pharmaceutical development and quality information to include in new drug applications (NDAs) and abbreviated new drug applications (ANDAs).

Zurück

GMP Seminare nach Thema